The hormone responsive region of mouse mammary tumor virus positions a nucleosome and precludes access of nuclear factor I to the promoter

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 1-2, 1996, Pages 19-31

  Candau, Reyes ^a,b   Chávez, Sebastian ^a   Beato, Miguel ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR I;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; CYTOCHEMISTRY; GENE TRANSFER; GENETIC TRANSCRIPTION; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUCLEOSOME; PROMOTER REGION;

ANIMALIA; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; ONCOVIRINAE; SACCHAROMYCES CEREVISIAE; TUMOR VIRUS;

EID: 0343867155     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00262-2     Document Type: Article

References (58)

1. Truss M., Bartsch J., Schelben A. Haché R. J. G. and Beato M.: Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J. 14 (1995) 1737-1751.
2. Kornberg R. D. and Lorch Y.: Irresistible force meets immovable object: transcription and the nucleosome. Cell 67 (1991) 833-836.
3. Truss M. and Beato M.: Steroid hormone receptors. Interaction with DNA and transcription factors. Endocr. Rev. 14 (1993) 459-479.
4. Perlmann T. and Wrange Ö.: Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J. 7 (1988) 3073-3079.
5. Piña B., Truss M., Ohlenbusch H., Postma J. and Beato M.: DNA rotational positioning in a regulatory nucleosome is determined by base sequence. An algorithm to model the preferred superhelix. Nucl. Acids Res. 18 (1990) 6981-8987.
6. Archer T. K., Cordingley M. G., Wolford R. G. and Hager G. L.: Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Molec. Cell. Biol. 11 (1991) 688-698.
7. Richard-Foy H. and Hager G. L.: Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J. 6 (1987) 2321-2328.
8. Cordingley M. G., Riegel A. T. and Hager G. L.: Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo. Cell 48 (1987) 261-270.
9. Beato M.: Transcriptional regulation of mouse mammary tumor virus by steroid hormones. Crit. Rev. Oncogen. 2 (1991) 195-210.
10. Zaret K. S. and Yamamoto K. R.: Reversible and persistent changes in chromatin structure accompanying activation of a glucocorticoid-dependent enhancer element. Cell 38 (1984) 29-38.
11. Piña B., Barettino D. and Beato M.: Nucleosome positioning and regulated gene expression. In Oxford Surveys on Eukaryotic Genes (Edited by N. MacLean). Oxford University Press, Oxford (1991) pp. 83-117.
12. Brüggemeier U., Rogge L., Winnacker E. L. and Beato M.: Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J. 9 (1990) 2233-2239.
13. Möws C., Preiss T., Slater E. P., Cao X., Verrijzer C. P., van der Vliet P. and Beato M.: Two independent pathways for transcription from the MMTV promoter. J. Steroid Biochem. Molec. Biol. 51 (1994) 21-32.
14. Archer T. K., Lefebvre P., Wolford R. G. and Hager G. L.: Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 255 (1992) 1573-1576.
15. Cereghini S. and Yaniv M.: Assembly of transfected DNA into chromatin: structural changes in the origin-promoter-enhancer region upon replication. EMBO J. 3 (1984) 1243-1253.
16. Piña B., Haché R. J. G., Arnemann J., Chalepakis G., Slater E. P. and Beato M.: Hormonal induction of transfected genes depends on DNA topology. Molec. Cell. Biol. 10 (1990) 625-633.
17. Cordingley M. G. and Hager G. L.: Binding of multiple factors to the MMTV promoter in crude and fractionated nuclear extracts. Nucl. Acids Res. 16 (1988) 609-630.
18. Sadowski I., Ma J., Triezenberg S. and Ptashne M.: GAL4-VP16 is an unusually potent transcriptional activator. Nature 335 (1988) 563-564.
19. Chalepakis G., Fritsch R., Fickenscher H., Deutsch U., Goulding M. and Gruss P.: The molecular basis of the undulated/Pax-1 mutation. Cell 66 (1991) 873-884.
20. Meisterernst M., Rogge L., Foeckler R., Karaghiosoff M. and Winnacker E. L.: Structural and functional organization of a porcine gene coding for nuclear factor I. Biochemistry 28 (1989) 8191-8200.
21. Annweiler A., Muller-Immerglück M. and Wirth T.: Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Molec. Cell. Biol. 12 (1992) 3107-2116.
22. Santoro C., Mermod N., Andrews P. C. and Tjian R.: A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cD-NAs. Nature 334 (1988) 218-224.
23. Kalff M., Gross B. and Beato M.: Progesterone receptor stimulates transcription of mouse mammary tumour virus in a cell-free system. Nature 344 (1990) 360-362.
24. Brüggemeier U., Kalff M., Franke S., Scheidereit C. and Beato M.: Ubiquitous transcription factor OTF-1 mediates induction of the mouse mammary tumour virus promoter through synergistic interaction with hormone receptors. Cell 64 (1991) 565-572.
25. Wright A. P. H., Carlstedt-Duke J. and Gustafsson J. A.: Ligand-specific transactivation of gene expression by a derivative of the human glucocorticoid receptor expressed in yeast. J. Biol. Chem. 265 (1990) 14,763-14,769.
26. Altmann H., Wendler W. and Winnacker E. L.: Transcriptional activation by CTF proteins is mediated by a bipartite low-proline domain. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 3901-3905.
27. Ammerer G.: Gene expression in yeast with the ADC1 promoter. Meth. Enzymol. 101 (1994) 192-201.
28. Cato A. C. B., Miksicek R., Schütz G., Arnemann J. and Beato M.: The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. EMBO J. 5 (1986) 2237-2240.
29. Gorman C. M., Moffat L. F. and Howard B. H.: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molec. Cell. Biol. 2 (1982) 1044-1051.
30. Rothstein R., Helms C. and Rosenberg N.: Concerted deletions and inversions are caused by mitotic recombination. Molec. Cell. Biol. 7 (1987) 1198-1207.
31. Kaiser C., Michaelis S. and Mitchel A.: Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, New York (1994).
32. Guarente L.: Yeast promoters and lacZ fusions designed to study expression of cloned genes. Meth. Enzymol. 101 (1983) 81-191.
33. Piña B., Brüggemeier U. and Beato M.: Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter. Cell 60 (1990) 719-731.
34. Gill G. and Ptashne M.: Negative effect of the transcriptional activator GAL4. Nature 334 (1988) 721-724.
35. Miksicek R., Borgmeyer U. and Nowock J.: Interaction of the TGGCA-binding protein with upstream sequences is required for efficient transcription of mouse mammary tumor virus. EMBO J. 6 (1987) 1355-1360.
36. Langer S. J. and Ostrowski M. C.: Negative regulation of transcription in vitro by a glucocorticoid response element is mediated by a trans-acting factor. Molec. Cell. Biol. 8 (1988) 3872-3881.
37. Tanaka H., Dong Y., Li Q., Okret S. and Gustafsson J.-A.: Identification and characterization of a cis-acting element that interferes with glucocorticoid-inducible activation of the mouse mammary tumor virus promoter. Proc. Natn. Acad. Sci. U.S.A. 88 (1991) 5393-5397.
38. Härtig E., Nierlich B., Mink S., Nebl G. and Cato A. C. B.: Regulation of expression of mouse mammary tumor virus through sequences located in the hormone response element. Involvement of cell-cell contact and a negative regulatory factor. J. Virol. 67 (1993) 813-821.
39. Scheidereit C., Geisse S., Westphal H. M. and Beato M.: The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour. Nature 304 (1983) 749-752.
40. Scheidereit C. and Beato M.: Contacts between receptor and DNA double helix within a glucocorticoid regulatory element of mouse mammary tumor. Proc. Natn. Acad. Sci. U.S.A. 81 (1984) 3029-3033.
41. Lopata M. A., Cleveland D. W. and Sollner-Webb B.: High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-Dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. Nucl. Acids Res. 12 (1984) 5707-5717.
42. Truss M., Bartsch J. and Beato M.: Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 11,333-11,337.
43. Lee J. W., Moffitt P. G., Morley K. L. and Peterson D. O.: Multipartite structure of a negative regulatory element associated with a steroid hormone-inducible promoter. J. Biol. Chem. 266 (1991) 24,101-24,108.
44. Morley K. L., Toohey M. G. and Peterson D. O.: Transcriptional repression of a hormone responsive promoter. Nucl. Acids Res. 15 (1987) 6973-6989.
45. Cereghini S., Raymondjean M., Garcia C., Herbomel P. and Yaniv M.: Factors involved in control of tissue-specific expression of albumin gene. Cell 50 (1987) 627-638.
46. Alwine J. C.: Transient gene expression control: effects of transfected DNA stability and trans-activation by viral enhancer proteins. Molec. Cell. Biol. 5 (1985) 1034-1042.
47. Chávez S., Candau R., Truss M. and Beato M.: Constitutive repression and nuclear factor 1 - dependent hormone activation of the mouse mammary tumor virus promoter in Saccharomyces cerevisiae. Mol. Cell Biol. 15 (1995) 6987-6998.
48. Stern S. and Herr W.: The Herpes Simplex Virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Gene Devel. 5 (1991) 2555-2566.
49. Cleary M. A., Stern S. Tanaka M. and Herr W.: Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. Genes and Devel. 7 (1993) 72-83.
50. Stringer K. F., Ingles C. J. and Greenblatt J.: Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature 345 (1990) 783-786.
51. Lin Y. S., Ha I., Maldonado E. Reinberg D. and Green M. R.: Binding of general transcription factor TFIIB to an acidic activating region. Nature 353 (1991) 569-571.
52. Lin Y.-S. and Green M. R.: Mechanism of action of an acidic transcriptional activator. Cell 64 (1991) 971-981.
53. White J., Brou C., Wu J., Lutz Y., Moncollin V. and Chambon P.: The acidic transcriptional activator GAL-VP16 acts on preformed template-committed complexes. EMBO J. 11 (1992) 2229-2240.
54. Workman J. L., Taylor I. C. A. and Kingston R. E.: Activation domains of stably bound GAL4 derivatives alleviate repressions of promoters by nucleosomes. Cell 64 (1991) 533-544.
55. Croston G. E., Laybourn P. J., Paranjape S. M. and Kadonaga J. T.: Mechanism of transcriptional antirepression by GAL4-VP16. Genes and Devel. 6 (1992) 2270-2281.
56. Lorch Y., Lapointe J. W. and Kornberg R. D.: Initiation on chromatin templates in a yeast RNA polymerase-II transcription system. Genes and Devel. 6 (1992) 2282-2287.
57. Workman J. L. and Kingston R. E.: Nucleosome core displacement in vitro via a metastable transcription factor-nucleosome complex. Science 258 (1992) 1780-1784.
58. Pham T. A., Elliston J. F., Nawaz Z., McDonnell D. P., Tsai M. J. and O'Malley B. W.: Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target genes. Proc. Natn. Acad. Sci. U.S.A. 88 (1991) 3125-3129.